RIVS (AccuCath Device) Versus (Conventional) PIV Catheter

This study is designed to evaluate user/physician preference as it relates to use of a
510(k) cleared vascular access and catheter device compared with conventional
needle/catheter vascular access devices, in terms of first stick success rates, dwell time,
device related vascular complications and adverse events and overall user and patient
satisfaction. As noted above, the study is designed to formally test the hypothesis that the
AccuCath™ System will exhibit superiority in terms of the rate of successful first attempt
peripheral IV placement, higher completion of therapy, fewer complications, longer dwell
times and higher user satisfaction compared to Conventional IV Catheters.

Inclusion Criteria:

1. Male or female, age > or equal to 18 years or < or equal to 89 years old;

2. Capable and willing to give informed consent;

3. English speaking;

4. Acceptable candidate for an elective, non-emergent PIV as determined by ordering
physician;

5. Admitted to study inpatient unit.

Exclusion Criteria:

1. Male or female, < 18 years old or > 89 years old;

2. Requirement for emergent IV placement (patient's condition would be compromised if
there is a delay in IV placement);

3. Previous venous grafts or surgery at the target vessel access site;

4. Currently involved in other investigational clinical trials (unless permission is
granted by other study PI);

5. Females who are pregnant, planning to become pregnant within 3 months of the
procedure, or lactating.